CClinicalTrials.gg
Status unknownNCT05695235Updated Jan 25, 2023

Monitoring Sleep, Wellbeing, and Glucose Metabolism in PGY1s

An observational study in Sleep and Glucose Metabolism Disorders, sponsored by National University of Singapore. Status unknown at 1 site in Singapore. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-01-25.

Sponsored by National University of Singapore · Observational

The sponsor has not verified this record recently (last verified Jan 2023), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
80
Ages
21 Years and older
Sex
All
01

Study summary

Overnight on-call schedules can impact sleep, wellbeing, and alertness, which can be detrimental on the performance, physical and mental health of residents. Moreover, rotating shift work may have a long-term negative health impact (e.g. increased risk of diabetes). Within the National University Hospital (NUH), two different systems of rotating on-call schedules are implemented. In the night float system, residents work from 8 pm to 8 am for 5 - 7 consecutive nights once every month, compared to the traditional overnight on-call system, where each resident is on call for 4-6 nights per month (7 am - 5 pm, followed by overnight call until 8 am the next morning). The aim of the current study is to track sleep, wellbeing, and glucose metabolism during the different phases of the night float and traditional on-call schedules.

Read the detailed description

Overnight on-call schedules can impact sleep, wellbeing, and alertness, which can be detrimental on the performance, physical and mental health of residents. Moreover, rotating shift work may have a long-term negative health impact (e.g. increased risk of diabetes). Within the National University Hospital (NUH), two different systems of rotating on-call schedules are implemented. In the night float system, residents work from 8 pm to 8 am for 5 - 7 consecutive nights once every month, compared to the traditional overnight on-call system, where each resident is on call for 4-6 nights per month (7 am - 5 pm, followed by overnight call until 8 am the next morning). The aim of the current study is to track sleep, wellbeing, and glucose metabolism during the different phases of the night float and traditional on-call schedules.

The availability of accurate mobile methodologies to monitor sleep and metabolic health provide new avenues for the improvement of sleep health and well-being. Wearable sleep tracking devices and smartphone apps provide remarkable opportunities for non-invasive, longitudinal sleep detection. Measurement of sleep during different stages of the shift schedule (baseline, on-call, recovery) can provide detailed insights into the temporal impact of the different schedules. Moreover, self-reported ratings of sleep quality, wellbeing, and time-use (delivered through phone-based e-diary methods) can further detail the mental health impact associated with these schedules.

Wearable continuous glucose monitoring systems (CGMS) provide a minimally invasive means of passively tracking ambulant interstitial fluid glucose levels in real time.

02

Conditions studied

  • Sleep
  • Glucose Metabolism Disorders
03

In context

Metabolic Diseases

997 studies on the registry are indexed under Metabolic Diseases; 234 are open to participants now.

This study's planned enrollment of 80 is below the median of 176 across 300 observational studies indexed under Metabolic Diseases.

Browse Metabolic Diseases studies →

Lead sponsor

National University of Singapore is the lead sponsor of 206 studies on the registry; 52 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

NUHS Postgraduate year 1 doctors

Inclusion criteria

  • NUHS Postgraduate year 1 doctors
  • Above 21 years of age
  • Completing their year 1 rotations in 2021 or 2022

Exclusion criteria

Exclusion Criteria:

  • As this is an observational study with minimal risk, in an restricted pool of participants, no further exclusion criteria will be applied for participation.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
80 participants (estimated)
Patient registry
No

Groups and cohorts

  • Traditional call

    In the traditional overnight on-call system, each resident is on call for 4-6 nights per month (7 am - 5 pm, followed by overnight call until 8 am the next morning)

    Device: CGM · Device: Oura ring · Behavioral: Cognitive tasks and questionnaires

  • Float call

    In the night float system, residents work from 8 pm to 8 am for 5 - 7 consecutive nights once every month

    Device: CGM · Device: Oura ring · Behavioral: Cognitive tasks and questionnaires

Interventions

  • DeviceCGM

    Wearable continuous glucose monitoring systems (CGMS) provide a minimally invasive means of passively tracking ambulant interstitial fluid glucose levels in real time.

  • DeviceOura ring

    Wearable sleep tracking device

  • BehavioralCognitive tasks and questionnaires

    Participants will be prompted daily to fill out a short set of wellbeing questions and perform a short alertness test on their mobile phones and laptop.

06

What researchers measure

Primary outcomes

  1. Sleep

    Sleep duration and timing will be measured

    Time frame: 8 weeks

  2. Wellbeing

    Participants will complete a daily micro questionnaire delivered through a mobile phone-based application. The investigators will examine mood ratings and stress ratings. Participants will be asked to respond to questions such as "How are you feeling right now?", rating their response from 'Negative' to 'Positive' on a 100-points sliding bar, "How stressed are you feeling right now?", rating their response from 'Not at all stressed' to 'Very stressed' on a 100-points sliding bar.

    Time frame: 8 weeks

  3. Glucose monitoring

    Blood glucose will be recorded using a wearable continuous glucose monitoring sensor (CGM: FreeStyle Libre Pro iQ by Abbott). CGM period will be individually scheduled to coincide with at least one cycle of day shift-night shift- recovery for each participant.

    Time frame: 2 weeks

  4. Alertness

    Participants will complete a daily set of cognitive games, delivered through a mobile phone-based application. The outcome measure from the games is a 3-min psychomotor vigilance task measuring sustained attention. Specifically, the investigators examine median reaction time and lapses (reaction time \> 500ms).

    Time frame: 8 weeks

07

Study locations

1 of 1 sites recruiting
  • National University of Singapore
    Singapore, (No States Listed) 117597, Singapore
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 25, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05695235
Lead sponsor
National University of Singapore
Responsible party
Michael W.L. Chee (Professor, National University of Singapore) — Principal investigator
First posted
Jan 23, 2023
Start date
Jan 1, 2022
Primary completion
Jun 2023 (estimated)
Completion
Jun 2023 (estimated)
Last update
Jan 25, 2023

Study contacts

Stijn Agus Adrianus Massar, PhD
Contact
mdcsaam@nus.edu.sg
+65 66015238

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion